Shasha Chen1, Beicheng Sun2, Zhongjun Dong3

  • 1Department of Allergy, the First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei 230032, China; Innovative Institute of Tumor Immunity and Medicine (ITIM), Hefei 230032, China; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei 230032, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China.

Cancer cell
|March 1, 2024
PubMed
概括

结合Adapalene,一个视网膜酸受体 (RAR) 激动剂,与Docetaxel化疗,诱导瘤细胞衰老. 这种方法增强了抗瘤免疫反应,特别是涉及自然杀手细胞.